Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xinglong Liu, Wencong Liu, Chuanbo Ding, Yingchun Zhao, Xueyan Chen, Dong Ling, Yinan Zheng & Zhiqiang Cheng. (2021) Taxifolin, Extracted from Waste Larix olgensis Roots, Attenuates CCl4-Induced Liver Fibrosis by Regulating the PI3K/AKT/mTOR and TGF-β1/Smads Signaling Pathways. Drug Design, Development and Therapy 15, pages 871-887.
Read now
Read now
Articles from other publishers (3)
Svenja Nölting, Jakob Rentsch, Helma Freitag, Katharina Detjen, Franziska Briest, Markus Möbs, Victoria Weissmann, Britta Siegmund, Christoph J. Auernhammer, Elke Tatjana Aristizabal Prada, Michael Lauseker, Ashley Grossman, Samantha Exner, Christian Fischer, Carsten Grötzinger, Jörg Schrader & Patricia Grabowski. (2017) The selective PI3Kα inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models. PLOS ONE 12:8, pages e0182852.
Crossref
Crossref
Attila Szabo, Tunde Fekete, Gabor Koncz, Brahma V. Kumar, Kitti Pazmandi, Zsofia Foldvari, Balazs Hegedus, Tamas Garay, Attila Bacsi, Eva Rajnavolgyi & Arpad Lanyi. (2016) RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1. Cellular Signalling 28:5, pages 335-347.
Crossref
Crossref
F Amoroso, M Capece, A Rotondo, D Cangelosi, M Ferracin, A Franceschini, L Raffaghello, V Pistoia, L Varesio & E Adinolfi. (2015) The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34:41, pages 5240-5251.
Crossref
Crossref